converting between glp-1 agonists Strategies to Enhance the Therapeutic Efficacy of GLP‐1 Receptor through Structural Modification and Carrier Delivery - Zhang - 2025 - ChemBioChem Switching between GLP‐1 receptor agonists
Description
GLP-1 drugs were associated with a lower incidence of ten OACs compared to insulin
Muscle is not cosmetic tissue
The risk of hospitalization for heart failure remains poorly understood, and risk factors such as prior heart failure and chronic kidney disease should be considered when prescribing this class of therapy [47]
11 A study has shown that GLP-1Rs are increased in the visceral adipose tissue of morbidly obese patients with insulin resistance
Conversely, blocking the Notch signal leads to the expression of Atoh1 , which induces secretory progenitors [20]
